| ā | Age (years)/sex | Comorbidities | Transthoracic echocardiography | Left ventricular EF (%) | Oral medications |
| 1 | 30/M | Htn, | Dilated LV, severe MR, mild TR, mild PAH | 24 | Metoprolol, OHA | 2 | 34/M | Htn, type II DM | Concentric LVH, dilated LV, global hypokinesia, no PAH | 35 | Clonidine, nifedipine, OHA | 3 | 38/M | Htn, type II DM | Mild concentric LVH, dilated LV, mild MR, no PAH | 40 | Nifedipine, clonidine, metoprolol, prazosin, insulin | 4 | 38/F | Htn | Moderate LVH, dilated LV, global hypokinesia, mild MR, no PAH | 24 | Metoprolol, clonidine | 5 | 42/M | Htn, type II DM | Mild concentric LVH, dilated LV, mild MR, mild PAH | 34 | Metoprolol, insulin | 6 | 45/M | Htn | Mild concentric LVH, dilated LV global hypokinesia severe TR, moderate MR, moderate PAH | 15 | Amlodipine, clonidine, metoprolol | 7 | 46/M | Htn, type II DM | LVH, dilated LV, mild MR, moderate PAH | 40 | Amlodipine, metoprolol, prazosin, insulin | 8 | 46/M | Htn | Dilated LV, global hypokinesia, moderate MR, moderate TR, mild PAH | 25 | Metoprolol |
|
|
M: male, F: female, Htn: hypertension, DM: diabetes mellitus, LV: left ventricle, MR: mitral regurgitation, TR: tricuspid regurgitation, PAH: pulmonary artery hypertension, OHA: oral hypoglycaemic agents, LVH: left ventricular hypertrophy.
|